The 5th Annual Cardiometabolic Risk in Inflammatory Conditions: Emerging Insights and Treatment of Inflammation in Cardiovascular Disease is dedicated to addressing the management of patients at elevated risk of cardiovascular and cardiometabolic disease linked to systemic inflammation.